Bayer AG is predicting that its Xarelto, a drug to prevent stroke, will reach peak annual sales. Bayer AG said it expects Xarelto, its new promising drug for treating and preventing stroke, to reach peak annual sales at the end of the decade, company's chief executive Marijin Dekker said in a statement.
Healthcare Health/Fitness
Royalty Pharma Offers US$6.6Bln Offer for Elan
Royalty Pharma offers US$11 per Elan share. While Elan is in the process of selling its fifty percent share in the successful multiple scelerosis drug Tysabri with its US partner Biogen Idec, here comes American investment firm Royalty Pharma offering US6.
Valeant Active on Equity Activities
Valean Pharmaceuticals active to deal but limited in cash. Valeant Pharmaceuticals International Inc is now on a spending spree, actively pursuing both merger and acquisition possibilities according to its CEO Michael Pearson.
India Cipla to Take Over South Africa Cipla
Cipla Ltd offers to take over Cipla Medpro South Africa. Two Ciplas from two continents would merge into one. Indian pharmaceutical company Cipla Ltd increased its offer by 17% to fully acquire South African drug company Cipla Medpro South Africa Ltd.
Mylan to Purchase Strides Injectables
Mylan increases market share with Stride purchase. The world's second largest stand alone generic drugs maker, Mylan Inc has agreed to purchase Stride Acroblab Ltd's injectable medicine unit.
Latest News
Mylan Inc. agreed with Strides Arcolab for the acquisition of Bangalore, India-based injectables unit.
Orbimed expands into Indian healthcare industry. Orbimed Advisors of New York is now preparing to launch its second Pan Asia Healthcare Fund by the end of 2013.
Endo gains strength with new CEO. The share values of the maker of the popular Percocet, Endo Health Solutions Inc increased after a month in the doldrums after the announcement of the appointment of its new CEO.
Carestream up for bids. Medical imaging and healthcare technology solutions provider Carestream Health Inc is now in the process of searching for a buyer for its assets.
Richter partners with marketing arm to conquer Chinese market. Richter, the Hungarian drug maker has just entered into a joint venture partnership to be able to market its products better in the world's largest market, China.
Richter has said that it has formed a new joint venture with its marketing partner to improve direct presence in the Chinese pharmaceutical market.
Royalty Pharma has been making big approaches to acquire the royalty rights for Tysabri from the Irish drug maker.
Elan profits from Tysabri sale offered to shareholders. Elan, the Irish drug firm has announced it would return US$1 billion to its shareholders from the proceeds of the sale of its stake in multiple sclerosis drug Tysabri to partner Biogen Idec.
The following bids, mergers, acquisitions and disposals were reported on Tuesday The following bids, mergers, acquisitions and disposals were reported by 1500 GMT on Tuesday: - Capital One Financial Corp said it agreed to sell to Citigroup Inc its $7 billion portfolio of private label and co-branded credit card accounts linked to electronics retailer Best Buy Co Inc.
